$CW · CURTISS WRIGHT CORP
Curtiss-Wright reported Q3 2026 (ended September 30, 2026) results: sales of $952.6M, up 10%; GAAP diluted EPS of $3.77; adjusted diluted EPS of $3.94, up 16%. Adjusted operating income rose 11% to $189M with adjusted operating margin of 19.9% (up 30 bps). Free cash flow was $157M (108% conversion). New orders of $1.1B (up 15%, 1.1x book-to-bill) and backlog of $4.6B (up 12% YTD). The company raised full-year 2026 guidance for sales, operating income, margin, EPS, and FCF.
- Adjusted diluted EPS of $3.94, up 16% year-over-year.
- Sales of $952.6M, up 10%; adjusted operating margin 19.9%, up 30 bps.
- New orders of $1.1B, up 15%, at 1.1x book-to-bill; backlog $4.6B, up 12% YTD.
- Repurchased ~538,000 shares for ~$352M; board added $510M authorization to $700M total.
- Full-year 2026 adjusted EPS guidance raised to $15.40-$15.60, up 16-18%.
Extended-hours last trade $465.38, +2.93% vs regular close, +3.54% vs price-at-filing, reflecting a positive reaction to the guidance raise and EPS beat.
A broad guidance raise with double-digit order and backlog growth signals durable defense and commercial nuclear momentum.
Defense and commercial nuclear demand drove growth, with naval (Columbia/Virginia-class submarines) and commercial nuclear advanced reactors as key drivers.
Defense Electronics segment operating margin fell 220 bps to 27.0% on unfavorable product mix and higher R&D investment; free cash flow declined 11% year-over-year.